Poor Drug Quality and Global Trade: A Pilot Study
Roger Bate, Ginger Jin, Aparna Mathur and Amir Attaran ,
NBER Working Paper

Experts claim that some Indian drug manufacturers cut corners and make substandard drugs for markets with non-existent, under-developed or emerging regulatory oversight, notably Africa. This paper assesses the quality of 1470 antibiotic and tuberculosis drug samples in solid oral form (tablet or capsule) that claim to be made in India and were sold in Africa, India, and five mid-income non-African countries.

Links to Researchers